DexCom Inc.

(DXCM) Trade

By |

Profile

Dexcom designs and commercializes continuous glucose monitoring (CGM) systems for diabetics. CGM systems serve as an alternative to the traditional glucometer process, and the company sells three different pieces of equipment, a sensor, a transmitter, and a receiver.

Contact Information

Website: www.dexcom.com
Email: investorrelations@dexcom.com
Main Phone: +1 858 200-0200
Address: 6340 Sequence Drive
State: CA
City / Town: San Diego
Country: USA
Postal Code: 92121

Issuer Information

Exchange: NGS
CEO: Kevin R. Sayer
Employees: 2990
NAICS: Medical Laboratories(621511)
$ 123.02 $ -1.5 (-1.20%)
Last Price 123.02 Change $ -1.5 Change % -1.20 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 124.90 High 125.72 Low 121.12 Prev Close 124.52
Last Trade Volume 1 mi 52 Wk Hi 152.14 52 Wk Low 51.04
Market Cap 10.9 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 88,844,345.00 EPS (TTM) 0.47 PE Ratio 264.90 Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 30 114
Number of Buys 14 30
Number of Sells 16 84
Net Activity -17470 246850
Last 10 Buys Shares
Steven R. Altman 1,000
Steven R. Altman 1,000
Jay S. Skyler 1,000
Martin L. Doordan 1,000
Martin L. Doordan 1,000
Martin L. Doordan 1,000
Jay S. Skyler 1,000
Jay S. Skyler 1,000
Martin L. Doordan 1,000
Last 10 Sell Shares
Eric Topol 1,000
Richard Doubleday 1,000
Terrance H. Gregg 1,000
Jay S. Skyler 1,000
Jake Leach 1,000
Kevin R. Sayer 1,000
Jake Leach 1,000
Jay S. Skyler 1,000
Jake Leach 1,000
Jake Leach 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 106 100 100 116
Low Target Price Estimate 55 55 55 55
Mean Target Price Estimate 84.07 83.2 81.87 90.14
Standard Deviation 14.26 13.74 13.51 16.36
Date of Most Recent Estimate 06/06/18 05/25/18 05/11/18 06/12/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 13 12 12 11
Moderate Buy 0 0 0 0
Hold 3 4 5 6
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 1.59 1.71 1.78 1.89